BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 36385663)

  • 1. The role of ferroptosis in neurodegenerative diseases.
    Xu Y; Zhao J; Zhao Y; Zhou L; Qiao H; Xu Q; Liu Y
    Mol Biol Rep; 2023 Feb; 50(2):1655-1661. PubMed ID: 36385663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
    Wang Y; Lv MN; Zhao WJ
    Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytosis/Ferroptosis in Neurodegeneration: the Underlying Role of Master Regulator Glutathione Peroxidase 4 (GPX4).
    Dar NJ; John U; Bano N; Khan S; Bhat SA
    Mol Neurobiol; 2024 Mar; 61(3):1507-1526. PubMed ID: 37725216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis and Its Role in Diverse Brain Diseases.
    Weiland A; Wang Y; Wu W; Lan X; Han X; Li Q; Wang J
    Mol Neurobiol; 2019 Jul; 56(7):4880-4893. PubMed ID: 30406908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases.
    Sun Y; Xia X; Basnet D; Zheng JC; Huang J; Liu J
    Front Aging Neurosci; 2022; 14():904152. PubMed ID: 35837484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ferroptosis in neurological diseases.
    Yao MY; Liu T; Zhang L; Wang MJ; Yang Y; Gao J
    Neurosci Lett; 2021 Mar; 747():135614. PubMed ID: 33485988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the potential role of ferroptosis in neurodegenerative diseases.
    Ji Y; Zheng K; Li S; Ren C; Shen Y; Tian L; Zhu H; Zhou Z; Jiang Y
    Front Cell Neurosci; 2022; 16():1005182. PubMed ID: 36385946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases.
    Wang Y; Li H; He Q; Zou R; Cai J; Zhang L
    Apoptosis; 2024 Feb; 29(1-2):3-21. PubMed ID: 37848673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics.
    Li Z; Zhang Y; Ji M; Wu C; Zhang Y; Ji S
    Biomed Pharmacother; 2024 Jul; 176():116777. PubMed ID: 38795640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic inhibition of ferroptosis in neurodegenerative disease.
    Ryan SK; Ugalde CL; Rolland AS; Skidmore J; Devos D; Hammond TR
    Trends Pharmacol Sci; 2023 Oct; 44(10):674-688. PubMed ID: 37657967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
    Xiang Y; Song X; Long D
    Arch Toxicol; 2024 Mar; 98(3):579-615. PubMed ID: 38265475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology.
    Wang Y; Tang B; Zhu J; Yu J; Hui J; Xia S; Ji J
    Int J Biol Sci; 2022; 18(10):4260-4274. PubMed ID: 35844784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases.
    Wang L; Fang X; Ling B; Wang F; Xia Y; Zhang W; Zhong T; Wang X
    Front Cell Neurosci; 2024; 18():1359453. PubMed ID: 38515787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse and neurodegenerative diseases: focus on ferroptosis.
    Guo C; Chen L; Wang Y
    Arch Toxicol; 2023 Jun; 97(6):1519-1528. PubMed ID: 37100932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight Into the Role of Ferroptosis in Non-neoplastic Neurological Diseases.
    Lei J; Chen Z; Song S; Sheng C; Song S; Zhu J
    Front Cell Neurosci; 2020; 14():231. PubMed ID: 32848622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
    Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
    J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?
    Viktorinova A; Durfinova M
    Neurosci Lett; 2021 Feb; 745():135627. PubMed ID: 33440237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifaceted role of ferroptosis in cardiovascular disease.
    Li C; Zhu X; Chen J; Xie X; Liang S; Liu X; Gong Q; Guo J
    Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(2):183-193. PubMed ID: 36815377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Ferroptosis and Other Types of Cell Death in Neurodegenerative Diseases.
    Dang X; Huan X; Du X; Chen X; Bi M; Yan C; Jiao Q; Jiang H
    Neurosci Bull; 2022 Aug; 38(8):938-952. PubMed ID: 35482278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.